Asif Ali, Chief Financial Officer at Protagonist Therapeutics, Inc (PTGX), sold 49,806 shares at $58.73 ($2.9M) on 2025-03-12, disclosed to the SEC on 2025-03-14.
Open-market sale of $2.9M PTGX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.73 | 24,903 | $1.5M | 50.0% |
| 2 | $58.73 | 24,903 | $1.5M | 50.0% |
| Total | $58.73 avg | 49,806 | $2.9M | 100% |
| Filing → |
| PTGX | SELL | 2026-03-27 | $2.6M | — | Filing → |
| PTGX | SELL | 2026-01-27 | $3.8M | — | Filing → |
| PTGX | SELL | 2026-01-21 | $708K | — | Filing → |